E2 ModerateModerate confidencePEM not requiredObservationalPeer-reviewedMachine draft
Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID.
Haran, John P, Bradley, Evan, Zeamer, Abigail L et al. · JCI insight · 2021 · DOI
Quick Summary
This study looked at bacteria in the mouth of people with COVID-19 to understand why some people develop long COVID. Researchers found that people with long COVID had higher levels of inflammation-causing bacteria, particularly types called Prevotella and Veillonella. Interestingly, the oral bacteria patterns in long COVID patients resembled those seen in chronic fatigue syndrome patients, suggesting the microbiome may play a role in prolonged illness.
Why It Matters
This research provides evidence that oral microbiome dysbiosis may contribute to long COVID, a condition that shares clinical features with ME/CFS. Understanding microbial drivers of prolonged inflammation could open new diagnostic and therapeutic avenues for both long COVID and ME/CFS patients, potentially through targeted microbiome interventions.
Observed Findings
- Patients with long COVID had significantly higher abundances of pro-inflammatory bacterial genera Prevotella and Veillonella
- Lipopolysaccharide-producing bacterial species were enriched in patients with prolonged COVID-19 symptoms
- The oral microbiome composition of long COVID patients was similar to that of chronic fatigue syndrome patients
- 63% of followed COVID-19 patients developed ongoing symptomatic COVID-19; 37% progressed to long COVID
Inferred Conclusions
- Oral microbiome dysbiosis, characterized by increased inflammatory bacteria, is associated with prolonged COVID-19 symptom duration
- The microbial dysbiosis pattern observed in long COVID overlaps with that seen in ME/CFS, suggesting common pathophysiologic mechanisms
- Oral microbiome dysfunction may contribute to the pathogenesis of long COVID through sustained inflammatory responses
Remaining Questions
- Does the dysbiotic microbiome cause prolonged symptoms, or is it a secondary consequence of viral persistence or immune dysregulation?
- What mechanisms do Prevotella and Veillonella-derived lipopolysaccharides use to perpetuate inflammation in long COVID?
- Would microbiome-targeted interventions (prebiotics, probiotics, or antimicrobials) ameliorate long COVID symptoms?
What This Study Does Not Prove
This study demonstrates association, not causation—it does not prove that dysbiosis causes long COVID symptoms or that restoring the microbiome would resolve illness. The study also does not establish whether microbiota changes are a cause, consequence, or epiphenomenon of prolonged infection. Additionally, findings from one microbiome compartment (oral) may not reflect systemic dysbiosis.
Tags
Symptom:Fatigue
Biomarker:CytokinesBlood Biomarker
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:Weak Case DefinitionExploratory OnlyMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →